open access

Vol 72, No 1 (2022)
Letter to the Editor
Published online: 2021-12-13
Get Citation

Is the elimination of cervical cancer now 3 times easier? One-dose vaccine efficacy has far-reaching implications

Paweł Koczkodaj1, Joakim Dillner2, Marta Manczuk1
·
Nowotwory. Journal of Oncology 2022;72(1):65-66.
Affiliations
  1. Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  2. Karolinska Institute, Stockholm, Sweden

open access

Vol 72, No 1 (2022)
Letter to the Editor
Published online: 2021-12-13

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Is the elimination of cervical cancer now 3 times easier? One-dose vaccine efficacy has far-reaching implications

Journal

Nowotwory. Journal of Oncology

Issue

Vol 72, No 1 (2022)

Article type

Letter to the Editor

Pages

65-66

Published online

2021-12-13

Page views

5280

Article views/downloads

271

DOI

10.5603/NJO.a2021.0078

Bibliographic record

Nowotwory. Journal of Oncology 2022;72(1):65-66.

Authors

Paweł Koczkodaj
Joakim Dillner
Marta Manczuk

References (7)
  1. Kunitoki K, Funato M, Mitsunami M, et al. Access to HPV vaccination in Japan: Increasing social trust to regain vaccine confidence. Vaccine. 2021; 39(41): 6104–6110.
  2. Karafillakis E, Simas C, Jarrett C, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019; 15(7-8): 1615–1627.
  3. Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021; 194: 245–251.
  4. Basu P, Malvi S, Joshi S, et al. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. The Lancet Oncology. 2021; 22(11): 1518–1529.
  5. Garland SM, Stanley MA, Giuliano AR, et al. IPVS Policy Committee. IPVS statement on "Temporary HPV vaccine shortage: Implications globally to achieve equity". Papillomavirus Res. 2020; 9: 100195.
  6. Bosch FX, Robles C, Díaz M, et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nat Rev Clin Oncol. 2016; 13(2): 119–132.
  7. Dillner J, Elfström KM, Baussano I. Prospects for accelerated elimination of cervical cancer. Prev Med. 2021; 153: 106827.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl